Lifespan counts the years a person lives and healthspan counts the years lived without significant limitation, and across wealthy countries the two figures have drifted apart. The gap is largely a product of what medicine has become good at.
What each measure counts
Lifespan is simple to record: birth to death, captured in registries and averaged into life expectancy. It requires no judgement about how those years were spent.
Healthspan requires a threshold — the point at which someone is counted as living with meaningful disease or disability. That threshold is a definition rather than an observation.
Research groups draw it in different places, using self-reported health, diagnosed conditions, or difficulty with everyday tasks such as climbing stairs. Healthspan figures from different sources are therefore not directly comparable.
Medicine turns fatal events into chronic ones
The largest gains in life expectancy over the last century came from preventing deaths, first from infectious disease and later from heart attack and stroke.
Treatment that stops an acute event from being fatal does not usually restore the tissue already damaged. A person survives with reduced heart function instead of dying.
Each such survival adds years to lifespan and frequently adds years spent managing a condition. The success itself is part of why the gap has widened.
Risk accumulates silently for decades
Arterial stiffening, bone loss and declining kidney filtration progress for years without producing symptoms, and none of them announce a start date.
Because the process is quiet, the point at which it becomes limiting seems sudden from the person's point of view while having been underway a long time.
This is why work aimed at healthspan concentrates on midlife, when the trajectory is largely set but the limitation has not yet arrived.
Function declines on several tracks at once
Muscle mass, aerobic capacity, cognition, hearing and balance each fall at their own rate, and independence is usually determined by whichever declines first.
Healthspan is therefore a moving bottleneck. Improving one system does not extend function if another becomes the limiting factor shortly afterwards.
A study measuring a single marker can show a genuine effect on that marker without changing the year at which a person loses independence.
Why the distinction changes what gets studied
A trial powered on deaths must follow people until enough have died, which demands many years and very large numbers of participants.
Trials using functional endpoints — walking speed, grip strength, time to a first disabling event — read out sooner, but they inherit whichever definition was chosen.
Reading any longevity claim starts with identifying the endpoint measured, because a result about a laboratory marker and a result about years of independent living are different findings entirely.